EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aberrant expression of the MID1 protein in neurons of Huntington’s disease brain

Adriana Geraci, Annika Reisbitzer, Janina Gerhard, Sybille Krauß

Frontiers in Genetics · 11.03.2026 · 17

DOI: 10.3389/fgene.2026.1753495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 11.03.2026. Verfasst von Adriana Geraci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Human- and Neurobiology, Institute of Biology, Department Chemistry and Biology, University of Siegen, Siegen, Germany. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huntington’s disease (HD) is caused by a CAG repeat expansion mutation in the Huntingtin ( HTT ) gene that transcribes into mRNA and translates into a polyglutamine tract. The mutant HTT gene products drive pathological changes that result in neurodegeneration. The mutant CAG repeat RNA contributes to cellular dysfunction by aberrantly recruiting RNA-binding proteins. For example, the mutant HTT transcript associates with a protein complex containing the MID1 protein. This aberrant recruitment of the MID1 protein complex results in an increased translation of mutant HTT . MID1 expression is abnormally high in both the brains of HD mouse models and HD patients. However, the cell type in which MID1 is overexpressed in HD brains remains obscure. Here, we investigated the MID1 expression in different brain cell types of an HD mouse model. Therefore, we separated neurons, astrocytes and microglia via magnetic sorting and show that MID1 is overexpressed in neurons of an HD mouse model. Moreover, we stained MID1 in brain sections of HD mice via immunohistochemistry and observed MID1 overexpressing cells in cortex. This finding shows that MID1 is highly expressed in neurons–the most vulnerable cell type in HD–underlining its important role in the neurodegenerative process. This supports the concept of blocking the interaction between MID1 and mutant HTT mRNA to counteract mutant HTT translation as a promising therapeutic approach.

Schlagwörter

Stichwörter der Autor:innen

Huntington’s diseaseMID1RNA-binding proteintranslation regulationubiquitin ligase

Autor:innen und Institutionen

  • Human- and Neurobiology, Institute of Biology, Department Chemistry and Biology, University of Siegen, Siegen, Germany.

Zitieren

APA

Geraci, A., Reisbitzer, A., Gerhard, J., & Krauß, S. (2026). Aberrant expression of the MID1 protein in neurons of Huntington’s disease brain. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1753495

Vancouver

Geraci A, Reisbitzer A, Gerhard J, Krauß S. Aberrant expression of the MID1 protein in neurons of Huntington’s disease brain. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1753495

BibTeX
@article{Geraci2026,
  author = {Geraci, Adriana and Reisbitzer, Annika and Gerhard, Janina and Krauß, Sybille},
  title = {Aberrant expression of the MID1 protein in neurons of Huntington’s disease brain},
  journal = {Frontiers in Genetics},
  year = {2026},
  volume = {17},
  doi = {10.3389/fgene.2026.1753495}
}
Kostenlos starten →